A three-tier workflow architecture.
Zymetra's operational model is structured to serve high-volume institutional procurement with regulatory precision at every stage — no handoff introduces variance or documentation gaps.
Regulatory Sync
Export documentation, CE/ISO/FDA alignment, customs support across destination markets.
Institutional Flow
Hospital tenders, logistics orchestration, and full batch tracking for procurement teams.
Strategic Sourcing
WHO-GMP partner audits, raw material vetting, and long-term supply agreements.
Audited excellence.
The standards below are held by our manufacturing partners and govern the products we source and distribute. Zymetra's own statutory licenses are listed in the section that follows.
Manufacturing partners audited to WHO Good Manufacturing Practice standards.
Products sourced from facilities operating ISO 13485:2016 quality management systems.
Devices distributed under manufacturer-held CE conformity for European market access.
Zymetra holds CDSCO Form 20B & 21B; documentation aligned with Indian and US regulatory frameworks.
Statutory documentation.
Our complete regulatory portfolio — drug licenses, foreign trade authorisation, and tax registration — verified and held on file. Originals available to qualified procurement partners on request.
Authorisation under the Drugs and Cosmetics Act for wholesale sale and distribution of drugs other than those specified in Schedules C and C(1). Issued by the State Drugs Control Department.
Authorisation for the wholesale distribution of specified drugs including biologicals and other regulated categories under Schedules C and C(1) of the Drugs and Cosmetics Rules.
Issued by the Directorate General of Foreign Trade, the IEC is the mandatory ten-digit identifier enabling Zymetra Medsystems to legally undertake import and export of medical devices and supplies across international borders.
Statutory registration under the Central Goods and Services Tax Act, 2017. Confirms the company's compliance with India's unified indirect tax framework for institutional supply and inter-state distribution.
Manufacturing & Supply Chain
Vetted supplier partnerships with rigorous procurement standards, QA protocols, and compliance verification.
WHO-GMP aligned facility audits, collaborative quality management, and long-term agreements.
40ft container shipments, urgent air-freight, full cold-chain, and customs clearance support.
India-wide institutional distribution, regional hubs, direct-to-hospital delivery, and international markets.
Future roadmap.
Capacity & Diversification
Supply expansion by Q4 2025 and launch of specialized medical device categories.
Geographic Expansion
Entry into African and Southeast Asian markets, plus Middle East institutional partnerships.
Global Leadership
R&D investment, sustainable manufacturing, and digital supply chain integration.